artemisinins - CISMeF

Preferred Label : artemisinins;

MeSH definition : A group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).;

Is substance : O;

Details

Origin ID

D037621;

UMLS CUI

C1136174;

ATC code(s)
- artemisinin [ATC Code]
ATC code(s)
- Artemisinin and derivatives, combinations [ATC Code]
- Artemisinin and derivatives, plain [ATC Code]
- artemisinin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Artemisinin [ICD-11 Extension code]
Currated CISMeF NLP mapping
- Artemisinin [NCIt concept]
- Artemisinin (substance) [SNOMED CT concept]
- artemisinin [SNOMED Notion]
Indexing information
- ascaridole [MeSH Supplementary Concept]
- yingzhaosu C [MeSH Supplementary Concept]
Pharmacological action(s)
- antimalarials [MeSH Descriptor]
Record concept(s)
- artemisinins [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-diethylamino-2-(10-dihydroartemisinoxy)ethane [MeSH Supplementary Concept]
- 1-dimethylamino-2-(10-dihydroartemisinoxy)ethane [MeSH Supplementary Concept]
- 1-morpholino-3-(10-dihydroartemisinoxy)propane [MeSH Supplementary Concept]
- 10-(2-(3-trifluoromethylphenylpiperazyl)ethyl)deoxoartemisinin [MeSH Supplementary Concept]
- 10-(4-trifluoromethylphenoxy)dihydroartemisinin [MeSH Supplementary Concept]
- 10-O-phenyl dihydroartemisinin ether [MeSH Supplementary Concept]
- 10-phenoxydihydroartemisinin [MeSH Supplementary Concept]
- 10beta-(trifluoropropyloxy)dihydroartemisinin [MeSH Supplementary Concept]
- 10beta-hydroxyartemisinin [MeSH Supplementary Concept]
- 12-allyldeoxoartemisinin [MeSH Supplementary Concept]
- 13-carbaartemisinin [MeSH Supplementary Concept]
- 15-hydroxy-10-deoxoartemisinin [MeSH Supplementary Concept]
- 3-(12-beta-artemisininoxy) phenoxyl succinic acid [MeSH Supplementary Concept]
- 3-alpha-hydroxyartemisinic acid [MeSH Supplementary Concept]
- 3-hydroxydeoxyartemisinin [MeSH Supplementary Concept]
- 5-hydroxyartemisinin [MeSH Supplementary Concept]
- 7-hydroxyartemisinin [MeSH Supplementary Concept]
- 9-(beta-dihydroartemisinoxy)methylanthracene [MeSH Supplementary Concept]
- 9-hydroxy-dihydroartemisinin [MeSH Supplementary Concept]
- 99-357 compound [MeSH Supplementary Concept]
- Artenimol-R [MeSH Supplementary Concept]
- CPH4-136 compound [MeSH Supplementary Concept]
- DC32 [MeSH Supplementary Concept]
- N-(2'-acetaldehydo)-11-azaartemisinin [MeSH Supplementary Concept]
- O-aminodihydroartemisinin [MeSH Supplementary Concept]
- SM1044 [MeSH Supplementary Concept]
- SM905 [MeSH Supplementary Concept]
- TPN10466 [MeSH Supplementary Concept]
- alpha-propoxycarbonyldihydroartemisine [MeSH Supplementary Concept]
- amodiaquine, artesunate drug combination [MeSH Supplementary Concept]
- anhydrodihydroartemisinin [MeSH Supplementary Concept]
- arteannuin B [MeSH Supplementary Concept]
- arteanuine B [MeSH Supplementary Concept]
- arteflene [MeSH Supplementary Concept]
- artelinic acid [MeSH Supplementary Concept]
- artemisic acid [MeSH Supplementary Concept]
- artemisin [MeSH Supplementary Concept]
- artemisinin [MeSH Supplementary Concept]
- artemisinin B [MeSH Supplementary Concept]
- artemisinin G [MeSH Supplementary Concept]
- artemisinin trioxane alcohol [MeSH Supplementary Concept]
- artemisinin-naphthoquine combination [MeSH Supplementary Concept]
- artemisitene [MeSH Supplementary Concept]
- artemisone [MeSH Supplementary Concept]
- artemotil [MeSH Supplementary Concept]
- artenibenzoate [MeSH Supplementary Concept]
- artenimol [MeSH Supplementary Concept]
- artesumycin [MeSH Supplementary Concept]
- artesunic acid [MeSH Supplementary Concept]
- beta-aminoarteether maleate [MeSH Supplementary Concept]
- beta-artecyclopropylmether [MeSH Supplementary Concept]
- beta-artecyclopropylmether HMCP-1 [MeSH Supplementary Concept]
- beta-artepipernoylether [MeSH Supplementary Concept]
- carboxypropyldeoxoartemisinine [MeSH Supplementary Concept]
- deoxoartemisinin [MeSH Supplementary Concept]
- deoxoartemisitene [MeSH Supplementary Concept]
- deoxyarteannuin B [MeSH Supplementary Concept]
- deoxyartemisinin [MeSH Supplementary Concept]
- dihydroartemisinic acid [MeSH Supplementary Concept]
- dihydroartemisinin 2-(biphenyl-2-yloxy)ethyl ether [MeSH Supplementary Concept]
- dihydroartemisinin 4-biphenylmethyl ether [MeSH Supplementary Concept]
- dihydroartemisinin beta-glucuronide [MeSH Supplementary Concept]
- ethyl 2-(4-(12-beta-artemisininoxy))phenoxylpropionate [MeSH Supplementary Concept]
- methyl artemisinate [MeSH Supplementary Concept]
- sulfadoxine-pyrimethamine-artesunate [MeSH Supplementary Concept]
- transtaganolide C [MeSH Supplementary Concept]
- transtaganolide D [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- artemisinin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients